Sheehan's syndrome overview: Difference between revisions
Iqra Qamar (talk | contribs) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Sheehan's syndrome}} | {{Sheehan's syndrome}} | ||
{{CMG}}; {{AE}} {{IQ}} | {{CMG}}; {{AE}}{{IQ}} | ||
==Overview== | ==Overview== | ||
Sheehan's syndrome is a life threatening [[complication]] of severe [[Postpartum haemorrhage|postpartum hemorrhage (PPH)]] and results in mild to severe [[hypopituitarism]]. It is less prevalent in developed countries but it is still one of the most common causes of [[hypopituitarism]] in underdeveloped and developing countries. During [[pregnancy]], enlarged size of [[pituitary gland]] and decreased blood supply to it due to any | Sheehan's syndrome is a life-threatening [[complication]] of severe [[Postpartum haemorrhage|postpartum hemorrhage (PPH)]] and results in mild to severe [[hypopituitarism]]. It is less prevalent in developed countries, but it is still one of the most common causes of [[hypopituitarism]] in underdeveloped and developing countries. During [[pregnancy]], enlarged size of [[pituitary gland]] and decreased blood supply to it due to any causes can result in [[ischemic necrosis]] of [[pituitary gland]]. Severe [[Postpartum Hemorrhage|PPH]], [[Glandular tissue|glandular]] [[hypertrophy]] and [[hyperplasia]], smaller [[Sella turcica|sella]] size, [[autoimmunity]], and [[Disseminated Intravascular Coagulation|disseminated vascular coagulation (DIC)]] are thought to play an important role in the [[pathogenesis]] of Sheehan's syndrome. The most common causes are including [[massive hemorrhage]] during [[parturition]], [[vascular]] compression, and vascular [[occlusion]]. Sheehan's syndrome needs to be differentiated from [[diseases]] causing [[hypopituitarism]] and other diseases like [[lymphocytic hypophysitis]], [[pituitary apoplexy]], [[hypothyroidism]], [[addison's disease]], [[empty sella syndrome]], [[Hypogonadotrophic hypogonadism|hypogonadotropic hypogonadism]], [[Simmond's Disease|simmond's disease]], hypoprolactinemia, and [[menopause]]. [[Risk factors]] causing Sheehan's syndrome include [[pregnancy]], [[Massive hemorrhage|severe/massive PPH]], pituitary mass, pre-existing [[Vascular disease|vascular diseases]], smaller and rigid [[Sella turcica|sella]], traumatic delivery, multiple [[Gestation|gestations]], [[placental]] abnormalities, and [[type 1 Diabetes]]. Sheehan's syndrome, if left untreated lead to [[panhypopituitarism]] and [[empty sella syndrome]]. Common [[complications]] include [[adrenal crisis]], [[hypotension]], [[hypothyroidism]], and [[hypopituitarism]]. [[Prognosis]] is generally excellent, providing early [[diagnosis]] and management may result in complete reversal of [[symptoms]]. [[Diagnosis]] of Sheehan's syndrome is made on clinical basis with a recent/remote history of traumatic [[delivery]] or delivery complicated by [[hypotension]]. The most common presentations are including [[postpartum]] lactation failure, [[amenorrhea]], loss of sexual hair, [[fatigue]], [[anorexia]], and [[weight loss]]. Clinical features depend on the severity of [[hypopituitarism]] that results from Sheehan's syndrome. Almost all the patients have [[Growth hormone|GH]], [[prolactin]], and [[gonadotropin]] deficiency; and the majority has [[Adrenocorticotropic hormone|ACTH]] and [[TSH]] deficiency. Laboratory evaluation gives a picture of partial or [[panhypopituitarism]]. Laboratory findings consistent with [[diagnosis]] of [[Sheehan's syndrome]] are including [[hyponatremia]], [[hypokalemia]], [[hypocalcemia]], [[hypomagnesemia]], [[hypophosphatemia]], [[anemia]], [[pancytopenia]], [[eosinophilia]], [[hypoalbuminemia]], low [[fasting plasma glucose]], and decreased levels of [[anterior pituitary]] [[hormones]] (free [[thyroxine]], [[estradiol]], and [[cortisol]] levels). The most sensitive test is inadequate [[prolactin]] and [[gonadotropin]] responses to stimulation. [[ECG]] findings associated with [[Sheehan's syndrome]] are including [[QT interval prolongation]], [[Brugada Syndrome|Type-1 Brugada-like ECG pattern]] (due to [[adrenal crisis]]), findings suggestive of [[cardiac tamponade]] ([[sinus tachycardia]], [[Low QRS voltage|low voltage QRS]], and [[electrical alternans]]), and [[dilated cardiomyopathy]]. [[Computed tomography|CT]] scan findings in case of [[acute]] presentation of Sheehan's syndrome may show non-[[hemorrhagic]] [[pituitary gland]] enlargement, while [[chronic]] presentation may show an [[empty sella]] or decreased [[Sella turcica|sellar]] volume. Findings on [[Magnetic resonance imaging|MRI]] suggestive of [[Sheehan's syndrome]] are including decreased [[Sella turcica|sellar]] volume, [[empty sella]], [[pituitary]] remnant tissue or [[Cerebrospinal fluid|CSF]] in the [[sella]].Treatment involves appropriate [[hormone replacement therapy]], which must be taken for the rest of your life, results in significant improvement and reversal of not only the physical symptoms, but also the [[psychological]] symptoms. | ||
==Historical Perspective== | ==Historical Perspective== | ||
Sheehan's syndrome was first discovered by Leon Konrad Gliński about a century ago and it was named after Harold Sheehan (1900-1988). | |||
==Classification== | ==Classification== | ||
There is no established system for the [[classification]] of Sheehan's syndrome | There is no established system for the [[classification]] of Sheehan's syndrome. | ||
==Pathophysiology== | ==Pathophysiology== | ||
It is thought that Sheehan's syndrome | It is thought that Sheehan's syndrome is the result of [[ischemic necrosis]] of [[pituitary gland]], due to [[pituitary gland]] [[Enlargement of organs|enlargement]] during [[parturition]]; precipitated by [[hypotension]] due to [[massive hemorrhage]]. Apart from [[pituitary gland]] enlargement during and before [[parturition]], [[vasospasm]], generalized [[Schwartzman phenomenon]], [[thrombosis]] and compression of the hypophyseal arteries, [[autoimmunity]], [[DIC]], and smaller size of [[Sella turcica|sella]] are thought to play a contributing role in [[pathogenesis]] of Sheehan syndrome.[[Occlusion]] and other [[Vascular anomaly|vascular anomalies]] of the [[hypophyseal portal system]] can also cause [[complications]] in the exchange of [[hormones]] between the [[hypothalamus]] and the [[pituitary gland]], leading to [[hypopituitarism]]. Sheehan's syndrome may result in mild to severe [[pituitary]] dysfunction (partial or [[panhypopituitarism]]), which is identified with growth hormone ([[GH|GH)]], [[thyroid hormone]], [[glucocorticoid]], [[gonadotropins]], and [[prolactin]] [[Hormone|hormone deficiencies]]; manifests as a wide spectrum of presentation. Usually, [[Growth hormone|GH]] is the earliest one to be lost. | ||
==Causes== | ==Causes== | ||
Common causes of Sheehan's syndrome | Common causes of Sheehan's syndrome are including [[massive hemorrhage]], [[Hypotension|hypotensio]]<nowiki/>n during pregnancy, [[vascular]] compression, and vascular [[occlusion]] ([[thrombosis]], [[DIC]]). Less common causes are including [[vascular insufficiency]] due to [[CABG|cronary artery bypass grafting (CABG)]] in older patients and snake bites (Russell's [[viper]] bites). | ||
==Differentiating | ==Differentiating Sheehan's syndrome from Other Diseases== | ||
Sheehan syndrome must be differentiated from [[lymphocytic hypophysitis]], [[pituitary apoplexy]], [[hypothyroidism]], [[Addison's disease]], [[panhypopituitarism]], [[empty sella syndrome]], [[hypogonadotropic hypogonadism]], [[Simmond's Disease|Simmond's disease]], hypoprolactinemia and [[menopause]]. | Sheehan's syndrome must be differentiated from [[lymphocytic hypophysitis]], [[pituitary apoplexy]], [[hypothyroidism]], [[Addison's disease]], [[panhypopituitarism]], [[empty sella syndrome]], [[hypogonadotropic hypogonadism]], [[Simmond's Disease|Simmond's disease]], hypoprolactinemia, and [[menopause]]. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
The [[incidence]] of Sheehan's syndrome is difficult to assess. | The [[incidence]] of Sheehan's syndrome is difficult to assess. It was found to be the 6th most common cause of [[Growth hormone|GH]] deficiency with an [[incidence]] of 3.1% of cases. In 2009, the [[prevalence]] of Sheehan's syndrome was estimated to be 5.1 per 100,000 women. It is less [[Prevalence|prevalent]] in [[Developed country|developed countries]] due to better [[obstetrical]] care and [[maternal health]] awareness. It is still one of the most common [[causes]] of [[hypopituitarism]] in developing countries. | ||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors in the development of Sheehan's syndrome include pregnancy, severe/massive PPH, pituitary mass, pre-existing vascular diseases, autoimmunity,type 1 | Common risk factors in the development of Sheehan's syndrome include [[pregnancy]], severe/massive [[PPH]], [[pituitary]] mass, pre-existing vascular diseases, [[autoimmunity]], [[Diabetes mellitus type 1|type 1 diabetes]], [[DIC]], smaller and rigid [[sella]], multiple [[Gestation|gestations]], [[placental]] abnormalities, and traumatic delivery. | ||
==Screening== | ==Screening== | ||
| Line 30: | Line 30: | ||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== | ||
Sheehan's syndrome, if left untreated lead to hypopituitarism and empty sella syndrome. Common complications | Sheehan's syndrome, if left untreated lead to [[hypopituitarism]] and [[empty sella syndrome]]. Common complications are including [[adrenal crisis]], [[hypotension]], [[hypothyroidism]], and [[hypopituitarism]]. [[Prognosis]] is generally excellent provided early [[diagnosis]] and management resulting in complete reversal of symptoms. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis is made on clinical basis with a recent/remote history of traumatic delivery or delivery complicated by hypotension. Diagnosis is mostly clinical but detailed medical history, measurement of pituitary hormone levels in blood, pituitary hormone stimulation tests and imaging (MRI preferred on CT) studies can help in making the diagnosis. | Diagnosis is made on clinical basis with a recent/remote history of traumatic delivery or delivery complicated by [[hypotension]]. Diagnosis is mostly clinical but detailed medical history, measurement of [[pituitary hormone]] levels in blood, [[pituitary hormone]] stimulation tests and imaging ([[MRI]] preferred on [[CT]]) studies can help in making the diagnosis. | ||
===History and Symptoms=== | ===History and Symptoms=== | ||
The most common symptoms of Sheehan's sydrome | The most common symptoms of Sheehan's sydrome are including agalactorrhea and failure to resume [[menstruation]] after [[parturition]]. Common symptoms are including [[hot flushes]], decreased [[Pubic hair|pubic]]/[[axillary hair]], [[hypotension]], [[hypoglycemia]], features of [[hypothyroidism]], [[hypoadrenalism]], and [[hypogonadism]]. | ||
===Physical Examination=== | ===Physical Examination=== | ||
Patients with syndrome usually appear fatigued and lethargic. Physical examination is usually remarkable for bradycardia, hypotension, pallor and signs suggestive of respective hormonal deficiency. | Patients with this syndrome usually appear fatigued and lethargic. Physical examination is usually remarkable for [[bradycardia]], [[hypotension]], [[pallor]], and signs suggestive of respective hormonal deficiency. | ||
===Laboratory Findings=== | ===Laboratory Findings=== | ||
Laboratory findings consistent with the diagnosis of Sheehan's syndrome include hyponatremia, hypokalemia, hypocalcemia, hypomagnesemia, hypophosphatemia, anemia, pancytopenia, eosinophilia, hypoalbuminemia, low fasting plasma glucose etc. | Laboratory findings consistent with the diagnosis of Sheehan's syndrome include [[hyponatremia]], [[hypokalemia]], [[hypocalcemia]], [[hypomagnesemia]], [[hypophosphatemia]], [[anemia]], [[pancytopenia]], [[eosinophilia]], [[hypoalbuminemia]], low [[fasting plasma glucose]], and etc. | ||
===Electrocardiogram=== | ===Electrocardiogram=== | ||
ECG findings associated with Sheehan's syndrome can include QT interval prolongation,Type-1 Brugada-like ECG pattern(due to adrenal crisis),findings suggestive of cardiac tamponade, dilated cardiomyopathy(multifactorial). | [[ECG]] findings associated with Sheehan's syndrome can include [[QT interval prolongation]],[[Brugada Syndrome|Type-1 Brugada-like]] [[ECG]] pattern (due to [[adrenal crisis]]), findings suggestive of [[cardiac tamponade]], [[dilated cardiomyopathy]] (multifactorial). | ||
===X-ray=== | ===X-ray=== | ||
There are no | There are no X-ray findings associated with Sheehan's syndrome. | ||
===CT scan=== | ===CT scan=== | ||
Acute presentation shows non-hemorrhagic pituitary gland enlargement while chronic presentation shows an empty sella or decreased sellar volume. | Acute presentation shows non-hemorrhagic [[pituitary]] gland enlargement while chronic presentation shows an [[empty sella]] or decreased [[sellar]] volume. | ||
===MRI=== | ===MRI=== | ||
Findings on MRI suggestive of Sheehan's syndrome | Findings on [[MRI]] suggestive of Sheehan's syndrome are including decreased [[sellar]] volume, [[empty sella]], [[pituitary]] remnant tissue, or [[CSF]] fluid in [[sella]]. | ||
===Ultrasound=== | ===Ultrasound=== | ||
[[Echocardiography]] findings associated with Sheehan's syndrome may include reversible [[dilated cardiomyopathy]] and [[pericardial effusion]]. | |||
===Other Imaging Findings=== | ===Other Imaging Findings=== | ||
| Line 66: | Line 66: | ||
==Treatment== | ==Treatment== | ||
===Medical Therapy=== | ===Medical Therapy=== | ||
Treatment involves appropriate hormone replacement therapy that results in complete recovery and reversal of symptoms. | Treatment involves appropriate [[hormone replacement therapy]] that results in complete recovery and reversal of symptoms. | ||
===Surgery=== | ===Surgery=== | ||
| Line 72: | Line 72: | ||
===Primary Prevention=== | ===Primary Prevention=== | ||
Effective measures for the primary prevention of Sheehan's syndrome | Effective measures for the primary prevention of Sheehan's syndrome are including improved [[obstetrical]] care and [[perinatal]] monitoring, prevention of [[pregnancy]] related complications, maternal awareness about Sheehan's syndrome and risk factors causing it, and post-puerperal follow up. | ||
===Secondary Prevention=== | ===Secondary Prevention=== | ||
Effective measures for the secondary prevention | Effective measures for the secondary prevention are including early diagnosis and treatment to prevent life threatening complications. | ||
==References== | ==References== | ||
Revision as of 14:13, 1 September 2017
|
Sheehan's syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sheehan's syndrome overview On the Web |
|
American Roentgen Ray Society Images of Sheehan's syndrome overview |
|
Risk calculators and risk factors for Sheehan's syndrome overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2]
Overview
Sheehan's syndrome is a life-threatening complication of severe postpartum hemorrhage (PPH) and results in mild to severe hypopituitarism. It is less prevalent in developed countries, but it is still one of the most common causes of hypopituitarism in underdeveloped and developing countries. During pregnancy, enlarged size of pituitary gland and decreased blood supply to it due to any causes can result in ischemic necrosis of pituitary gland. Severe PPH, glandular hypertrophy and hyperplasia, smaller sella size, autoimmunity, and disseminated vascular coagulation (DIC) are thought to play an important role in the pathogenesis of Sheehan's syndrome. The most common causes are including massive hemorrhage during parturition, vascular compression, and vascular occlusion. Sheehan's syndrome needs to be differentiated from diseases causing hypopituitarism and other diseases like lymphocytic hypophysitis, pituitary apoplexy, hypothyroidism, addison's disease, empty sella syndrome, hypogonadotropic hypogonadism, simmond's disease, hypoprolactinemia, and menopause. Risk factors causing Sheehan's syndrome include pregnancy, severe/massive PPH, pituitary mass, pre-existing vascular diseases, smaller and rigid sella, traumatic delivery, multiple gestations, placental abnormalities, and type 1 Diabetes. Sheehan's syndrome, if left untreated lead to panhypopituitarism and empty sella syndrome. Common complications include adrenal crisis, hypotension, hypothyroidism, and hypopituitarism. Prognosis is generally excellent, providing early diagnosis and management may result in complete reversal of symptoms. Diagnosis of Sheehan's syndrome is made on clinical basis with a recent/remote history of traumatic delivery or delivery complicated by hypotension. The most common presentations are including postpartum lactation failure, amenorrhea, loss of sexual hair, fatigue, anorexia, and weight loss. Clinical features depend on the severity of hypopituitarism that results from Sheehan's syndrome. Almost all the patients have GH, prolactin, and gonadotropin deficiency; and the majority has ACTH and TSH deficiency. Laboratory evaluation gives a picture of partial or panhypopituitarism. Laboratory findings consistent with diagnosis of Sheehan's syndrome are including hyponatremia, hypokalemia, hypocalcemia, hypomagnesemia, hypophosphatemia, anemia, pancytopenia, eosinophilia, hypoalbuminemia, low fasting plasma glucose, and decreased levels of anterior pituitary hormones (free thyroxine, estradiol, and cortisol levels). The most sensitive test is inadequate prolactin and gonadotropin responses to stimulation. ECG findings associated with Sheehan's syndrome are including QT interval prolongation, Type-1 Brugada-like ECG pattern (due to adrenal crisis), findings suggestive of cardiac tamponade (sinus tachycardia, low voltage QRS, and electrical alternans), and dilated cardiomyopathy. CT scan findings in case of acute presentation of Sheehan's syndrome may show non-hemorrhagic pituitary gland enlargement, while chronic presentation may show an empty sella or decreased sellar volume. Findings on MRI suggestive of Sheehan's syndrome are including decreased sellar volume, empty sella, pituitary remnant tissue or CSF in the sella.Treatment involves appropriate hormone replacement therapy, which must be taken for the rest of your life, results in significant improvement and reversal of not only the physical symptoms, but also the psychological symptoms.
Historical Perspective
Sheehan's syndrome was first discovered by Leon Konrad Gliński about a century ago and it was named after Harold Sheehan (1900-1988).
Classification
There is no established system for the classification of Sheehan's syndrome.
Pathophysiology
It is thought that Sheehan's syndrome is the result of ischemic necrosis of pituitary gland, due to pituitary gland enlargement during parturition; precipitated by hypotension due to massive hemorrhage. Apart from pituitary gland enlargement during and before parturition, vasospasm, generalized Schwartzman phenomenon, thrombosis and compression of the hypophyseal arteries, autoimmunity, DIC, and smaller size of sella are thought to play a contributing role in pathogenesis of Sheehan syndrome.Occlusion and other vascular anomalies of the hypophyseal portal system can also cause complications in the exchange of hormones between the hypothalamus and the pituitary gland, leading to hypopituitarism. Sheehan's syndrome may result in mild to severe pituitary dysfunction (partial or panhypopituitarism), which is identified with growth hormone (GH), thyroid hormone, glucocorticoid, gonadotropins, and prolactin hormone deficiencies; manifests as a wide spectrum of presentation. Usually, GH is the earliest one to be lost.
Causes
Common causes of Sheehan's syndrome are including massive hemorrhage, hypotension during pregnancy, vascular compression, and vascular occlusion (thrombosis, DIC). Less common causes are including vascular insufficiency due to cronary artery bypass grafting (CABG) in older patients and snake bites (Russell's viper bites).
Differentiating Sheehan's syndrome from Other Diseases
Sheehan's syndrome must be differentiated from lymphocytic hypophysitis, pituitary apoplexy, hypothyroidism, Addison's disease, panhypopituitarism, empty sella syndrome, hypogonadotropic hypogonadism, Simmond's disease, hypoprolactinemia, and menopause.
Epidemiology and Demographics
The incidence of Sheehan's syndrome is difficult to assess. It was found to be the 6th most common cause of GH deficiency with an incidence of 3.1% of cases. In 2009, the prevalence of Sheehan's syndrome was estimated to be 5.1 per 100,000 women. It is less prevalent in developed countries due to better obstetrical care and maternal health awareness. It is still one of the most common causes of hypopituitarism in developing countries.
Risk Factors
Common risk factors in the development of Sheehan's syndrome include pregnancy, severe/massive PPH, pituitary mass, pre-existing vascular diseases, autoimmunity, type 1 diabetes, DIC, smaller and rigid sella, multiple gestations, placental abnormalities, and traumatic delivery.
Screening
There is insufficient evidence to recommend routine screening for Sheehan's syndrome.
Natural History, Complications, and Prognosis
Sheehan's syndrome, if left untreated lead to hypopituitarism and empty sella syndrome. Common complications are including adrenal crisis, hypotension, hypothyroidism, and hypopituitarism. Prognosis is generally excellent provided early diagnosis and management resulting in complete reversal of symptoms.
Diagnosis
Diagnosis is made on clinical basis with a recent/remote history of traumatic delivery or delivery complicated by hypotension. Diagnosis is mostly clinical but detailed medical history, measurement of pituitary hormone levels in blood, pituitary hormone stimulation tests and imaging (MRI preferred on CT) studies can help in making the diagnosis.
History and Symptoms
The most common symptoms of Sheehan's sydrome are including agalactorrhea and failure to resume menstruation after parturition. Common symptoms are including hot flushes, decreased pubic/axillary hair, hypotension, hypoglycemia, features of hypothyroidism, hypoadrenalism, and hypogonadism.
Physical Examination
Patients with this syndrome usually appear fatigued and lethargic. Physical examination is usually remarkable for bradycardia, hypotension, pallor, and signs suggestive of respective hormonal deficiency.
Laboratory Findings
Laboratory findings consistent with the diagnosis of Sheehan's syndrome include hyponatremia, hypokalemia, hypocalcemia, hypomagnesemia, hypophosphatemia, anemia, pancytopenia, eosinophilia, hypoalbuminemia, low fasting plasma glucose, and etc.
Electrocardiogram
ECG findings associated with Sheehan's syndrome can include QT interval prolongation,Type-1 Brugada-like ECG pattern (due to adrenal crisis), findings suggestive of cardiac tamponade, dilated cardiomyopathy (multifactorial).
X-ray
There are no X-ray findings associated with Sheehan's syndrome.
CT scan
Acute presentation shows non-hemorrhagic pituitary gland enlargement while chronic presentation shows an empty sella or decreased sellar volume.
MRI
Findings on MRI suggestive of Sheehan's syndrome are including decreased sellar volume, empty sella, pituitary remnant tissue, or CSF fluid in sella.
Ultrasound
Echocardiography findings associated with Sheehan's syndrome may include reversible dilated cardiomyopathy and pericardial effusion.
Other Imaging Findings
There are no other imaging findings associated with Sheehan's syndrome.
Other Diagnostic Studies
There are no additional diagnostic findings for Sheehan's syndrome.
Treatment
Medical Therapy
Treatment involves appropriate hormone replacement therapy that results in complete recovery and reversal of symptoms.
Surgery
Surgical intervention is not recommended for the management of Sheehan's syndrome.
Primary Prevention
Effective measures for the primary prevention of Sheehan's syndrome are including improved obstetrical care and perinatal monitoring, prevention of pregnancy related complications, maternal awareness about Sheehan's syndrome and risk factors causing it, and post-puerperal follow up.
Secondary Prevention
Effective measures for the secondary prevention are including early diagnosis and treatment to prevent life threatening complications.